wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38403573-A50325F3-4049-415D-BBEA-4E5175552CD5
Q38403573-A50325F3-4049-415D-BBEA-4E5175552CD5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38403573-A50325F3-4049-415D-BBEA-4E5175552CD5
The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis.
P2860
Q38403573-A50325F3-4049-415D-BBEA-4E5175552CD5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38403573-A50325F3-4049-415D-BBEA-4E5175552CD5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b00fe8c4986bba49528a394b413794a1937dc73
P2860
JAK inhibition in the myeloproliferative neoplasms: lessons learned from the bench and bedside.